Answers are grounded in this paper and cite their sources.
Clinical study reveals membrane-dependent beta-2-microglobulin generation and superior clearance via hemodiafiltration in hemodialysis patients, indicating optimized filtration limits amyloidosis.
β₂-Microglobulin (β₂m) has been identified as the major constituent of dialysis-related amyloid. Although there is no clear correlation between absolute 62m levels and amyloidosis-related symptoms, elevated serum levels are thought to be the basis for tissue deposition of β₂m. Besides diminished renal excretion and insufficient removal during hemodialysis, a dialysis-related induction of β₂m production is discussed as the major cause of elevated serum 62m levels. In order to evaluate the influence of hemodialysis membranes and the hemodialysis procedure on 62m levels we determined serum β₂m levels in patients on chronic intermittent hemodialysis. Polymethylmethacrylate 2.0 m2, cuprophane and cellulose acetate dialyzers led to increasing β₂m levels during dialysis, which was in excess of what could be accounted for by hemoconcentration. The polymethylmethacrylate 1.6 m2 dialyzer did not result in a significant rise of β₂m levels during dialysis. This indicates that production of 62m is not only dependent on the membrane material but also on the surface area of the dialyzer. The use of polysulfone and hemophane low-flux dialyzers did not induce an increase in β₂m levels during dialysis but a significant clearance of β₂m was not demonstrable either. Volume-controlled dialysis with high-flux membranes (polysulfone 0.65 m2 and polysulfone 1.25 m2) lowered β₂m; clearance values, however, were significantly higher when these dialyzers were used in a hemodiafiltration procedure. We conclude from our study that some dialysis membranes appear to induce β₂m production, whereas others do not. Significant removal of β₂m, however, can be obtained by hemodiafiltration and a significant decrease of predialytic β₂m levels was obtained after only 2 months of application of this treatment regimen.
No takes yet. Share an insight, caveat, or question.
Mayer et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: